Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945129516> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2945129516 endingPage "S16" @default.
- W2945129516 startingPage "S16" @default.
- W2945129516 abstract "The autoantibody profile, which varies between races, has rarely been reported in Chinese Han systemic sclerosis (SSc) patients. The present study aims to investigate the autoantibody profile of Chinese Han SSc patients using a commercial line immunoassay.The prevalence of autoantibodies to Ro-52, PDGFR, Ku, PM75, PM100, Th/To, NOR90, Fib, RP155, RP11, CENP-B, CENP-A and Scl-70 were analyzed in serum samples obtained from healthy controls (n = 30), SSc patients (n = 320) and non-SSc connective-tissue disease patients (n = 100) using an Euroline Systemic Sclerosis Profile kit.SSc patients had increased prevalence of anti-RP11 (P = 0.032), anti-CENPB (P < 0.001), anti-CENPA (P = 0.001) and anti-Scl-70 (P < 0.001), but had decreased prevalence of anti-Ro-52 (P = 0.004), when compared to non-SSc CTDs. Furthermore, SSc patients had increased prevalence of anti-Ro-52 (P = 0.003), anti-CENPB (P = 0.034), anti-CENPA (P = 0.034) and anti-Scl-70 (P < 0.001), when compared to HCs. In addition, SSc patients with interstitial lung disease (ILD) had increased prevalence of anti-Ro-52 (P = 0.046) and anti-Scl-70 (P = 0.035), but had decreased prevalence of anti-CENPB (P < 0.001) and anti-CENPA (P < 0.001). Moreover, SSc patients with pulmonary arterial hypertension (PAH) had increased prevalence of anti-Ro-52 (P = 0.013) and decreased prevalence of anti-Scl-70 (P = 0.001). Anti-Ro-52 and anti-Scl-70 had increased values for predicting ILD in SSc patients, while anti-Ro-52 had increased values for predicting PAH in SSc patients.A commercial line immunoassay was used to evaluate the diagnostic value of autoantibodies in Chinese Han SSc patients. The results clearly indicate that the immunoblot assay has good diagnostic utility for SSc. Anti-Ro-52, anti-RP11, anti-CENPB, anti-CENPA and anti-Scl-70 are useful for diagnosing SSc in the Chinese Han population. Anti-Ro-52, anti-CENPB, anti-CENPA and anti-Scl-70 have a potential value for diagnosing ILD in SSc patients. Furthermore, anti-Ro-52 and anti-Scl-70 may be used to diagnose PAH in SSc patients." @default.
- W2945129516 created "2019-05-29" @default.
- W2945129516 creator A5012595476 @default.
- W2945129516 creator A5055229708 @default.
- W2945129516 creator A5056940169 @default.
- W2945129516 creator A5065104193 @default.
- W2945129516 creator A5075110651 @default.
- W2945129516 date "2019-06-01" @default.
- W2945129516 modified "2023-09-27" @default.
- W2945129516 title "Analytical evaluation of the Lumipulse G BRAHMS PCT procalcitonin immunoassay" @default.
- W2945129516 doi "https://doi.org/10.1016/j.cca.2019.03.043" @default.
- W2945129516 hasPublicationYear "2019" @default.
- W2945129516 type Work @default.
- W2945129516 sameAs 2945129516 @default.
- W2945129516 citedByCount "0" @default.
- W2945129516 crossrefType "journal-article" @default.
- W2945129516 hasAuthorship W2945129516A5012595476 @default.
- W2945129516 hasAuthorship W2945129516A5055229708 @default.
- W2945129516 hasAuthorship W2945129516A5056940169 @default.
- W2945129516 hasAuthorship W2945129516A5065104193 @default.
- W2945129516 hasAuthorship W2945129516A5075110651 @default.
- W2945129516 hasConcept C10936531 @default.
- W2945129516 hasConcept C126322002 @default.
- W2945129516 hasConcept C159654299 @default.
- W2945129516 hasConcept C163764329 @default.
- W2945129516 hasConcept C180032290 @default.
- W2945129516 hasConcept C203014093 @default.
- W2945129516 hasConcept C2776670291 @default.
- W2945129516 hasConcept C2777543607 @default.
- W2945129516 hasConcept C2777714996 @default.
- W2945129516 hasConcept C2778384902 @default.
- W2945129516 hasConcept C2779075594 @default.
- W2945129516 hasConcept C2779134260 @default.
- W2945129516 hasConcept C2779625490 @default.
- W2945129516 hasConcept C2779967694 @default.
- W2945129516 hasConcept C2780420688 @default.
- W2945129516 hasConcept C71924100 @default.
- W2945129516 hasConcept C90924648 @default.
- W2945129516 hasConceptScore W2945129516C10936531 @default.
- W2945129516 hasConceptScore W2945129516C126322002 @default.
- W2945129516 hasConceptScore W2945129516C159654299 @default.
- W2945129516 hasConceptScore W2945129516C163764329 @default.
- W2945129516 hasConceptScore W2945129516C180032290 @default.
- W2945129516 hasConceptScore W2945129516C203014093 @default.
- W2945129516 hasConceptScore W2945129516C2776670291 @default.
- W2945129516 hasConceptScore W2945129516C2777543607 @default.
- W2945129516 hasConceptScore W2945129516C2777714996 @default.
- W2945129516 hasConceptScore W2945129516C2778384902 @default.
- W2945129516 hasConceptScore W2945129516C2779075594 @default.
- W2945129516 hasConceptScore W2945129516C2779134260 @default.
- W2945129516 hasConceptScore W2945129516C2779625490 @default.
- W2945129516 hasConceptScore W2945129516C2779967694 @default.
- W2945129516 hasConceptScore W2945129516C2780420688 @default.
- W2945129516 hasConceptScore W2945129516C71924100 @default.
- W2945129516 hasConceptScore W2945129516C90924648 @default.
- W2945129516 hasLocation W29451295161 @default.
- W2945129516 hasOpenAccess W2945129516 @default.
- W2945129516 hasPrimaryLocation W29451295161 @default.
- W2945129516 hasRelatedWork W1595501421 @default.
- W2945129516 hasRelatedWork W2020803612 @default.
- W2945129516 hasRelatedWork W2033970484 @default.
- W2945129516 hasRelatedWork W2121599003 @default.
- W2945129516 hasRelatedWork W2411384577 @default.
- W2945129516 hasRelatedWork W2425879134 @default.
- W2945129516 hasRelatedWork W2754566777 @default.
- W2945129516 hasRelatedWork W3012815292 @default.
- W2945129516 hasRelatedWork W4309479314 @default.
- W2945129516 hasRelatedWork W2187340300 @default.
- W2945129516 hasVolume "493" @default.
- W2945129516 isParatext "false" @default.
- W2945129516 isRetracted "false" @default.
- W2945129516 magId "2945129516" @default.
- W2945129516 workType "article" @default.